Latest Announcements - Jiangxi Fushine Pharmaceutical Co., Ltd.

Jiangxi Fushine Pharmaceutical Co., Ltd.

CN

Please enter your search keywords!

CN

Latest Announcements

Latest Announcements

Home · Investor Relations · Latest Announcements ·

Latest Announcement

2025-05-16

Legal Opinion of Zhong Lun Law Firm, Beijing on the 2024 Annual General Meeting of Shareholders of Jiangxi Fushine Pharmaceutical Co., Ltd.

PDF
2025-05-16

Announcement of Jiangxi Fushine Pharmaceutical Co., Ltd. Regarding the Partial Share Pledge by the Company’s Controlling Shareholder

PDF
2025-05-16

Announcement on the Resolutions of the 2024 Annual General Meeting of Shareholders

PDF
2025-05-12

Announcement on Participating in the 2025 Online Collective Reception Day for Investors of Listed Companies in the Jiangxi Region

PDF
2025-04-30

Fushine Pharmaceuticals: Announcement on the Completion of Industrial and Commercial Registration Change and Renewal of Business License of Wholly-Owned Subsidiary

PDF
2025-04-26

Fushine Pharmaceuticals: Announcement on Re-appointment of Auditor for 2025

PDF
2025-04-26

Fushine Pharmaceuticals: 2024 Financial Results

PDF
2025-04-26

Fushine Pharmaceuticals: Supervisory Board Resolution Announcement

PDF
2025-04-26

Fushine Pharmaceuticals: Feasibility Analysis Report on Developing Foreign Exchange Hedging Business

PDF
2025-04-26

Fushine Pharmaceuticals: The board of directors' special opinion on the independence assessment of independent directors

PDF

Learn more

Jiangxi Fushine Pharmaceutical Co., Ltd.

Powered by Science, Driven by Life

Supply Inquiries: 0798-2692600

Sales Inquiries: 0798-2699911

infor@fushine.cn

Copyright © Jiangxi Fushine Pharmaceutical Co., Ltd.. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |